Replies to post #7740 on Sorrento Therapeutics Inc (SRNE)

[1776club]

How does this affect Sorrento's stock position in Celularity?
"The transaction will be effected pursuant to a merger of Celularity with a wholly owned subsidiary of GX Acquisition Corp. In the merger, outstanding shares of Celularity capital stock, options and warrants will be converted into shares of common stock, options and warrants, respectively, of the combined company at an implied Celularity equity value of $1.25 billion."